vs
Beam Therapeutics Inc.（BEAM）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
Beam Therapeutics Inc.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.6倍（$114.1M vs $70.9M），Beam Therapeutics Inc.净利率更高（214.1% vs -7.8%，领先221.8%），Beam Therapeutics Inc.同比增速更快（279.5% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
BEAM vs RICK — 直观对比
营收规模更大
BEAM
是对方的1.6倍
$70.9M
营收增速更快
BEAM
高出282.7%
-3.1%
净利率更高
BEAM
高出221.8%
-7.8%
自由现金流更多
RICK
多$98.5M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $70.9M |
| 净利润 | $244.3M | $-5.5M |
| 毛利率 | — | — |
| 营业利润率 | -15.3% | -0.7% |
| 净利率 | 214.1% | -7.8% |
| 营收同比 | 279.5% | -3.1% |
| 净利润同比 | 370.4% | -2354.9% |
| 每股收益（稀释后） | $2.53 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMRICK
| Q4 25 | $114.1M | — | ||
| Q3 25 | — | $70.9M | ||
| Q2 25 | — | $71.1M | ||
| Q1 25 | — | $65.9M | ||
| Q4 24 | — | $71.5M | ||
| Q3 24 | — | $73.2M | ||
| Q2 24 | — | $76.2M | ||
| Q1 24 | — | $72.3M |
净利润BEAMRICK
| Q4 25 | $244.3M | — | ||
| Q3 25 | — | $-5.5M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $244.0K | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | $774.0K |
营业利润率BEAMRICK
| Q4 25 | -15.3% | — | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 4.8% | ||
| Q2 24 | — | -3.3% | ||
| Q1 24 | — | 6.4% |
净利率BEAMRICK
| Q4 25 | 214.1% | — | ||
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | -6.9% | ||
| Q1 24 | — | 1.1% |
每股收益（稀释后）BEAMRICK
| Q4 25 | $2.53 | — | ||
| Q3 25 | — | $-0.60 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | — | $1.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.56 | ||
| Q1 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $1.2B | $261.1M |
| 总资产 | $1.5B | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资BEAMRICK
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $33.7M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | — | $34.7M | ||
| Q3 24 | — | $32.4M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | — | $20.0M |
总债务BEAMRICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BEAMRICK
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $261.1M | ||
| Q2 25 | — | $269.5M | ||
| Q1 25 | — | $268.8M | ||
| Q4 24 | — | $269.0M | ||
| Q3 24 | — | $263.4M | ||
| Q2 24 | — | $271.2M | ||
| Q1 24 | — | $285.8M |
总资产BEAMRICK
| Q4 25 | $1.5B | — | ||
| Q3 25 | — | $596.9M | ||
| Q2 25 | — | $597.4M | ||
| Q1 25 | — | $589.8M | ||
| Q4 24 | — | $586.2M | ||
| Q3 24 | — | $584.4M | ||
| Q2 24 | — | $601.0M | ||
| Q1 24 | — | $609.9M |
负债/权益比BEAMRICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $11.5M |
| 自由现金流率自由现金流/营收 | -76.3% | 16.2% |
| 资本支出强度资本支出/营收 | 3.3% | 3.2% |
| 现金转化率经营现金流/净利润 | -0.34× | — |
| 过去12个月自由现金流最近4个季度 | — | $34.9M |
8季度趋势，按日历期对齐
经营现金流BEAMRICK
| Q4 25 | $-83.3M | — | ||
| Q3 25 | — | $13.7M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | — | $13.3M | ||
| Q3 24 | — | $15.7M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | — | $10.8M |
自由现金流BEAMRICK
| Q4 25 | $-87.0M | — | ||
| Q3 25 | — | $11.5M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $3.2M |
自由现金流率BEAMRICK
| Q4 25 | -76.3% | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 4.4% |
资本支出强度BEAMRICK
| Q4 25 | 3.3% | — | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.6% |
现金转化率BEAMRICK
| Q4 25 | -0.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
